Funding and Investments

Jan 01, 2011
BioPharm International
Business models that were used to create current value are no longer going to be effective going forward.
Oct 01, 2010
BioPharm International
Biotech's mid-sized elites position themselves for growth.
Jul 01, 2010
BioPharm International
After a bright start to the year, some of biotech's blue chip companies have seen their early gains turn into losses.
Apr 01, 2010
BioPharm International
As the capital markets in the US and globally continue to strengthen, the biotech industry can expect to see a rise in initial public offerings this year.
Oct 01, 2009
BioPharm International
Biotech impressed investors with positive drug data, strong drug sales and earnings, and partnering deals.
Aug 01, 2009
BioPharm International
Contract research, development, and manufacturing organizations betting on a comeback in venture capital financing will have a long wait.
Jul 01, 2009
BioPharm International
Although the markets closed on a positive note in May, it will still take many more months before biotech starts on the road to full recovery.
May 01, 2009
BioPharm International
By BioPharm International Editors
Several legal considerations are key to protect the buyer and seller in royalty interest transactions.
Apr 01, 2009
BioPharm International
By BioPharm International Editors
Biodefense start-up companies have an abundance of options when seeking funding.
Apr 01, 2009
BioPharm International
Big biotechs will do just fine in the ongoing financial crisis, but the smaller companies will have more difficulty weathering the storm.
native1_300x100
lorem ipsum